Reardon Tighe

EDGAR CIK 0001760431

Janux Therapeutics, Inc. - JANX

  1. Manufacturing
  2. Chemicals
  3. Pharmaceutical Preparations
CFO
Acting Chief Financial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
0
$0
0 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
1
($7.18) M
-131,196 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
06/03/2024
06/05/2024
Sell
-131,196 @ $54.75
 ($7,182,981) 633,673 (-17.15%) Indirect - By Avalon BioVentures I, LP